A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).

NCT07638683 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
AL Amyloidosis

Interventions

DRUG: Teclistamab

Sponsor

Shanghai Zhongshan Hospital

Collaborators

[object Object]